US$ 24.10
bpc 157 clinical trial dosing BPC-157 Dosage Guide: Protocols & Safety 2026 Next week, July 23-24, the
Description
For multiple groups, the data were analyzed by one-way (ANOVA) followed by Tukeys and Dunnetts multiple comparison tests (details in figure legends)
Zatwierdzona zawarto substancji czynnej: 10,71 mg o czystoci powyej 99,8%
Thereby, prototype cytoprotective agent gastric pentadecapeptide BPC 157, which has been used in trials for ulcerative colitis and now for multiple sclerosis, would rescue IC lesions in rats (IC rats)

10.1523/JNEUROSCI.6390-11.2013 J

p = 0.658